Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6

Brain, Behavior, and Immunity

Volumn 26, Issue 6, 2012, Pages 959-971

  Nelson, T E ^a   Olde Engberink, A ^a,b   Hernandez, R ^a   Puro, A ^a   Huitron Resendiz, S ^a   Hao, C ^a   De Graan, P N E ^b   Gruol, D L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytokine; Electrophysiology; Field excitatory synaptic potential; Field potential recording; Hippocampal slice; Long term potentiation; Population spike; Post tetanic potentiation; Synaptic plasticity; Western blot

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 6; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTRIC POTENTIAL; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CA1 REGION, HIPPOCAMPAL; CENTRAL NERVOUS SYSTEM; DENDRITES; ELECTROPHYSIOLOGICAL PHENOMENA; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; INTERLEUKIN-6; LONG-TERM POTENTIATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; STAT3 TRANSCRIPTION FACTOR; SYNAPTIC TRANSMISSION;

EID: 84863878702     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.05.005     Document Type: Article

References (74)

1. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 1990, 4:2860-2867.
2. Andreasen M., Hablitz J.J. Paired-pulse facilitation in the dentate gyrus: a patch-clamp study in rat hippocampus in vitro. J. Neurophysiol. 1994, 72:326-336.
3. Andressen C., Blumcke I., Celio M.R. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res. 1993, 271:181-208.
4. Bajova H., Nelson T.E., Gruol D.L. Chronic CXCL10 alters the level of activated ERK1/2 and transcriptional factors CREB and NF-kB in hippocampal neuronal cell culture. J. Neuroimmunol. 2008, 195:36-46.
5. Balschun D., Wetzel W., Del Rey A., Pitossi F., Schneider H., Zuschratter W., Besedovsky H.O. Interleukin-6: a cytokine to forget. FASEB J. 2004, 18:1788-1790.
6. Bast T. Toward an integrative perspective on hippocampal function: from the rapid encoding of experience to adaptive behavior. Rev. Neurosci. 2007, 18:253-281.
7. Bauer J., Strauss S., Volk B., Berger M. IL-6-mediated events in Alzheimer's disease pathology. Immunol. Today 1991, 12:422.
8. Bellinger F.P., Madamba S.G., Campbell I.L., Siggins G.R. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci. Lett. 1995, 198:95-98.
9. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
10. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 1993, 90:10061-10065.
11. Cardinaux J.R., Allaman I., Magistretti P.J. Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 2000, 29:91-97.
12. Chiang C.-S., Stalder A., Samimi A., Campbell I.L. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci. 1994, 16:212-221.
13. Creager R., Dunwiddie T., Lynch G. Paired-pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus. J. Physiol. 1980, 299:409-424.
14. De Luca G., Di Giorgio R.M., Macaione S., Calpona P.R., Costantino S., Di Paola E.D., De Sarro A., Ciliberto G., De Sarro G. Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice. Pharmacol. Biochem. Behav. 2004, 78:75-81.
15. De Sarro G., Russo E., Ferreri G., Giuseppe B., Flocco M.A., Di Paola E.D., De Sarro A. Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacol., Biochem. Behav. 2004, 77:761-766.
16. Debanne D., Guerineau N.C., Gahwiler B.H., Thompson S.M. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. J. Physiol. 1996, 491:163-176.
17. Dobrunz L.E., Stevens C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 1997, 18:995-1008.
18. Dunwiddie T.V., Haas H.L. Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action. J. Physiol. 1985, 369:365-377.
19. Erickson M.A., Maramara L.A., Lisman J. A single brief burst induces GluR1-dependent associative short-term potentiation: a potential mechanism for short-term memory. J. Cogn. Neurosci. 2009, 22:2530-2540.
20. Gadient R.A., Otten U. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci. Lett. 1994, 182:243-246.
21. Gadient R.A., Otten U.H. Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 1997, 52:379-390.
22. Gallo P., Frei K., Rordorf C., Lazdins J., Tavolato B., Fontana A. Human immunodeficiency type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 1989, 23:109-116.
23. Getts D.R., Matsumoto I., Muller M., Getts M.T., Radford J., Shrestha B., Campbell I.L., King N.J. Role of IFN-gamma in an experimental murine model of West Nile virus-induced seizures. J. Neurochem. 2007, 103:1019-1030.
24. Gruol D.L., Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 1997, 15:307-339.
25. Hayley S., Anisman H. Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates. Curr. Pharm. Des. 2005, 11:947-962.
26. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 1990, 265:621-636.
27. Heyser C.J., Masliah E., Samimi A., Campbell I.L., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. USA 1997, 94:1500-1505.
28. Hirano T. The biology of interleukin-6. Chem. Immunol. 1992, 51:153-180.
29. Hull M., Strauss S., Berger M., Volk B., Bauer J. Inflammatory mechanisms in Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 1996, 246:124-128.
30. Jankowsky J.L., Derrick B.E., Patterson P.H. Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learning Memory 2000, 7:400-412.
31. Jankowsky J.L., Patterson P.H. Cytokine and growth factor involvement in long-term potentiation. Mol. Cell. Neurosci. 1999, 14:273-286.
32. Kalueff A.V., Lehtimaki K.A., Ylinen A., Honkaniemi J., Peltola J. Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neurosci. Lett. 2004, 365:106-110.
33. Kirkman N.J., Libbey J.E., Wilcox K.S., White H.S., Fujinami R.S. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 2010, 51:454-464.
34. Lauri S.E., Palmer M., Segerstrale M., Vesikansa A., Taira T., Collingridge G.L. Presynaptic mechanisms involved in the expression of STP and LTP at CA1 synapses in the hippocampus. Neuropharmacol. 2007, 52:1-11.
35. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
36. Lehtimaki K.A., Keranen T., Huhtala H., Hurme M., Ollikainen J., Honkaniemi J., Palmio J., Peltola J. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J. Neuroimmunol. 2004, 152:121-125.
37. Lehtimaki K.A., Peltola J., Koskikallio E., Keranen T., Honkaniemi J. Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res. Mol. Brain Res. 2003, 110:253-260.
38. Li A.J., Katafuchi T., Oda S., Hori T., Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 1997, 748:30-38.
39. Li G., Bauer S., Nowak M., Norwood B., Tackenberg B., Rosenow F., Knake S., Oertel W.H., Hamer H.M. Cytokines and epilepsy. Seizure 2011, 20:249-256.
40. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207:111-116.
41. Libbey J.E., Kennett N.J., Wilcox K.S., White H.S., Fujinami R.S. Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J. Virol. 2011, 85:6913-6922.
42. Maccaferri G., Dingledine R. Control of feedforward dendritic inhibition by NMDA receptor-dependent spike timing in hippocampal interneurons. J. Neurosci. 2002, 22:5462-5472.
43. Maimone D., Gregory S., Arnason B.G.W., Reder A.T. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol. 1991, 32:67-74.
44. Miller D.B., O'Callaghan J.P. Depression, cytokines, and glial function. Metabolism 2005, 54:33-38.
45. Millichap J.G., Millichap J.J. Role of viral infections in the etiology of febrile seizures. Pediatr. Neurol. 2006, 35:165-172.
46. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 1991, 176:593-598.
47. Miyamoto E. Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus. J. Pharmacol. Sci. 2006, 100:433-442.
48. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin-1b, interleukin-6, epidermal growth factor and transforming growth factor-a are elevated in the brain from parkinsonian patients. Neurosci. Lett. 1994, 180:147-150.
49. Nagatsu T., Mogi M., Ichinose H., Togari A. Cytokines in Parkinson's disease. J. Neural Transm. Suppl. 2000, 143-151.
50. Nelson T.E., Hao C., Manos J., Ransohoff R.M., Gruol D.L. Altered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression. Brain Behav. Immun. 2011, 25(Suppl. 1):S106-119.
51. Otmakhov N., Shirke A.M., Malinow R. Measuring the impact of probabilistic transmission on neuronal output. Neuron 1993, 10:1101-1111.
52. Peltola J., Hurme M., Miettinen A., Keranen T. Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 1998, 31:129-133.
53. Peng S., Zhang Y., Zhang J., Wang H., Ren B. Glutamate receptors and signal transduction in learning and memory. Mol. Biol. Rep. 2010, 38:453-460.
54. Penkowa M., Molinero A., Carrasco J., Hidalgo J. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience 2001, 102:805-818.
55. Ruan L., Kang Z., Pei G., Le Y. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease. Curr. Alzheimer Res. 2009, 6:531-540.
56. Sallmann S., Juttler E., Prinz S., Petersen N., Knopf U., Weiser T., Schwaninger M. Induction of interleukin-6 by depolarization of neurons. J. Neurosci. 2000, 20:8637-8642.
57. Samland H., Huitron-Resendiz S., Masliah E., Criado J., Henriksen S.J., Campbell I.L. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J. Neurosci. Res. 2003, 73:176-187.
58. Sanz E., Hofer M.J., Unzeta M., Campbell I.L. Minimal role for STAT1 in interleukin-6 signaling and actions in the murine brain. Glia 2008, 56:190-199.
59. Sauder C., de la Torre J.C. Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection. J. Neuroimmunol. 1999, 96:29-45.
60. Small S.A., Schobel S.A., Buxton R.B., Witter M.P., Barnes C.A. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 2011, 12:585-601.
61. Spooren A., Kolmus K., Laureys G., Clinckers R., De Keyser J., Haegeman G., Gerlo S. Interleukin-6, a mental cytokine. Brain Res. Rev. 2011, 67:157-183.
62. Steffensen S.C., Campbell I.L., Henriksen S.J. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 1994, 652:149-153.
63. Tagliari B., Tagliari A.P., Schmitz F., da Cunha A.A., Dalmaz C., Wyse A.T. Chronic variable stress alters inflammatory and cholinergic parameters in hippocampus of rats. Neurochem. Res. 2011, 36:487-493.
64. Tancredi V., D'Antuono M., Cafe C., Giovedi S., Bue M.C., D'Arcangelo G., Onofri F., Benfenati F. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J. Neurochem. 2000, 75:634-643.
65. Tehranian R., Hasanvan H., Iverfeldt K., Post C., Schultzberg M. Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576. Neurosci. Lett. 2001, 301:54-58.
66. Tyor W.R., Glass J.D., Griffin J.W., Becker P.S., McArthur J.C., Bezman L., Griffin D.E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 1992, 31:349-360.
67. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 2008, 22:797-803.
68. Vezzani A., Ravizza T., Balosso S., Aronica E. Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 2008, 49(Suppl. 2):24-32.
69. Vlkolinsky R., Siggins G.R., Campbell I.L., Krucker T. Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices. J. Neuroimmunol. 2004, 150:37-47.
70. Wei H., Chadman K.K., McCloskey D.P., Sheikh A.M., Malik M., Brown W.T., Li X. Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. Biochim. Biophys. Acta 2011, 1822:831-842.
71. Wei H., Zou H., Sheikh A.M., Malik M., Dobkin C., Brown W.T., Li X. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J. Neuroinflamm. 2011, 8:52.
72. Wu T.H., Lin C.H. IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions. Behav. Brain Res. 2008, 193:183-191.
73. Xiaoqin Z., Zhengli L., Changgeng Z., Xiaojing W., Li L. Changes in behavior and amino acid neurotransmitters in the brain of rats with seizure induced by IL-1beta or IL-6. J. Huazhong Univ. Sci. Technol. Med. Sci. 2005, 25:236-239.
74. Zucker R.S. Exocytosis: a molecular and physiological perspective. Neuron 1996, 17:1049-1055.